Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TMC125 study highlights failing NNRTI regimen task.

IAPAC monthly - 1 Nov 2006

Alcorn Keith

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials, Phase II as Topic
Share to HIV
Share to Nitriles
Share to Pyridazines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pyrimidines

Share to Randomized Controlled Trials as Topic

Share to Reverse Transcriptase Inhibitors

Share to Viral Load

Source

Identifiers

PMID: 17378070

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

TMC125 study highlights failing NNRTI regimen task.PMID 17378070Read ↗

DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label updateSemantic proximity Read ↗

Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). New NNRTI resistance mutations.Semantic proximity Read ↗

TMC 125 possibly effective against NNRTI-resistant HIV.Semantic proximity Read ↗

Cobicistat: Review of a Pharmacokinetic Enhancer for HIV InfectionSemantic proximity Read ↗

Building a better nucleoside/nucleotide analogue backbone: pharmacokinetic and resistance considerations.Semantic proximity Read ↗

Disparities in dosing, drug reduction, and drug discontinuation among US FDA approved tyrosine kinase inhibitorsSemantic proximity Read ↗

5-Aza-4′-thio-2′-deoxycytidine, a New Orally Bioavailable Nontoxic “Best-in-Class”: DNA Methyltransferase 1–Depleting Agent in Clinical DevelopmentSemantic proximity Read ↗

Tipranavir.Semantic proximity Read ↗

Next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors.Semantic proximity Read ↗

An open-label assessment of TMC 125--a new, next-generation NNRTI, for 7 days in HIV-1 infected individuals with NNRTI resistance.Semantic proximity Read ↗

Now Is the Time to Consider Personalized Effective Dose.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.